Tag: Phase 3 Trials
Lupin Completes Phase 3 Trials for Lucentis Biosimilar
Lupin Limited announced the successful completion of global Phase 3 trials for its Lucentis (ranibizumab) biosimilar, LUBT010. This trial, involving 600 patients from India,...
